392 related articles for article (PubMed ID: 11980881)
1. Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
Mori K; Gehlbach P; Ando A; Wahlin K; Gunther V; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1610-5. PubMed ID: 11980881
[TBL] [Abstract][Full Text] [Related]
2. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
3. Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies.
Akiyama H; Kachi S; Silva RL; Umeda N; Hackett SF; McCauley D; McCauley T; Zoltoski A; Epstein DM; Campochiaro PA
J Cell Physiol; 2006 May; 207(2):407-12. PubMed ID: 16419035
[TBL] [Abstract][Full Text] [Related]
4. Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus.
Park CY; Chuck RS; Cano M; Yew M; Nguyen V; Parker J; Mori K; Gehlbach PL
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):399-406. PubMed ID: 18172118
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of lentiviral transduction during development in normal and rd mice.
Pang J; Cheng M; Haire SE; Barker E; Planelles V; Blanks JC
Mol Vis; 2006 Jul; 12():756-67. PubMed ID: 16862069
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
[TBL] [Abstract][Full Text] [Related]
7. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
[TBL] [Abstract][Full Text] [Related]
8. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus vector-mediated in vivo gene transfer into adult murine retina.
Bennett J; Wilson J; Sun D; Forbes B; Maguire A
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2535-42. PubMed ID: 8163342
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral-mediated gene transfer to retinal explants during development and degeneration.
Pang J; Cheng M; Stevenson D; Trousdale MD; Dorey CK; Blanks JC
Exp Eye Res; 2004 Aug; 79(2):189-201. PubMed ID: 15325566
[TBL] [Abstract][Full Text] [Related]
11. Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector.
Kreppel F; Luther TT; Semkova I; Schraermeyer U; Kochanek S
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1965-70. PubMed ID: 12037006
[TBL] [Abstract][Full Text] [Related]
12. Nonviral ocular gene transfer.
Kachi S; Oshima Y; Esumi N; Kachi M; Rogers B; Zack DJ; Campochiaro PA
Gene Ther; 2005 May; 12(10):843-51. PubMed ID: 15789063
[TBL] [Abstract][Full Text] [Related]
13. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
[TBL] [Abstract][Full Text] [Related]
14. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
15. A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Müller cells.
Sakamoto T; Ueno H; Goto Y; Oshima Y; Ishibashi T; Inomata H
Gene Ther; 1998 Aug; 5(8):1088-97. PubMed ID: 10326032
[TBL] [Abstract][Full Text] [Related]
16. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector.
Li T; Adamian M; Roof DJ; Berson EL; Dryja TP; Roessler BJ; Davidson BL
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2543-9. PubMed ID: 8163343
[TBL] [Abstract][Full Text] [Related]
17. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
[TBL] [Abstract][Full Text] [Related]
18. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.
Gehlbach P; Demetriades AM; Yamamoto S; Deering T; Duh EJ; Yang HS; Cingolani C; Lai H; Wei L; Campochiaro PA
Gene Ther; 2003 Apr; 10(8):637-46. PubMed ID: 12692592
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
[TBL] [Abstract][Full Text] [Related]
20. Ocular gene transfer with self-complementary AAV vectors.
Yokoi K; Kachi S; Zhang HS; Gregory PD; Spratt SK; Samulski RJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3324-8. PubMed ID: 17591905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
